🇰🇷 Dipyrone in South Korea

Dipyrone (METAMIZOLE) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Dipyrone in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Pain approved in South Korea

Frequently asked questions

Is Dipyrone approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Dipyrone in South Korea?

Marketing authorisation holder not available in our data.